Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-139875
Filing Date
2012-03-29
Accepted
2012-03-29 16:30:59
Documents
13
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d305285d10k.htm 10-K 1535192
2 EX-21.1 d305285dex211.htm EX-21.1 3304
3 EX-23.1 d305285dex231.htm EX-23.1 1503
4 EX-23.2 d305285dex232.htm EX-23.2 1552
5 EX-31.1 d305285dex311.htm EX-31.1 8781
6 EX-31.2 d305285dex312.htm EX-31.2 8835
7 EX-32.1 d305285dex321.htm EX-32.1 4978
  Complete submission text file 0001193125-12-139875.txt   4746811

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT sgnt-20111231.xml EX-101.INS 675120
9 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20111231.xsd EX-101.SCH 19604
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20111231_cal.xml EX-101.CAL 41833
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnt-20111231_def.xml EX-101.DEF 39270
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20111231_lab.xml EX-101.LAB 177967
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20111231_pre.xml EX-101.PRE 122920
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 001-35144 | Film No.: 12724370
SIC: 2834 Pharmaceutical Preparations